EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Zeolitic Pyrimidine Framework ( ZPF ) Nanoplatform Co‐Delivers a DNAzyme and a Protein Prodrug for Cascade‐Activated Tumour Therapy

Yan Huang, Xingjie Hu, Jinli Sun, Min Yin, Nan Chen iD

Cell Proliferation · 2026

DOI: 10.1111/cpr.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2026. Verfasst von Yan Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Engineering Research Center of Green Energy Chemical Engineering, Key Laboratory of Resource Chemistry of Ministry of Education, Shanghai Fr…. Hauptthemen laut MEDLINE: Prodrugs, DNA, Catalytic, Pyrimidines, Zeolites. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic application of cytotoxic proteins like ribonuclease A (RNase A) is hindered by their systemic toxicity. Here, we engineer a protein‐structure‐directed zeolitic pyrimidine framework (ZPF) as a superior nanocarrier that co‐encapsulates and stabilizes a ROS‐responsive RNase A prodrug (RNBC) and a GPX‐1‐targeting DNAzyme with high efficiency. This DZ‐RNBC@ZPF nanocomplex, camouflaged with a 4T1 cell membrane, ensures tumour‐specific delivery and lysosomal degradation. The acidic environment triggers framework dissolution, releasing Zn 2+ to activate the DNAzyme. The DNAzyme downregulates GPX‐1, amplifying intracellular H 2 O 2 , which in turn cleaves the NBC group to activate the RNase A prodrug precisely within target cells. This coordinated intracellular cascade—from material degradation to enzymatic ROS amplification and prodrug activation—induces significant apoptosis in 4T1 cells and potently suppresses tumour growth in vivo. Our work establishes ZPF as an enabling platform for the co‐delivery of bioactive macromolecules and presents a novel therapeutic strategy based on a synergistic protein prodrug‐DNAzyme circuit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsDNA, CatalyticPyrimidinesZeolitesAntineoplastic AgentsNanoparticlesAnimalsMiceCell Line, TumorHumansMice, Inbred BALB CApoptosisFemaleReactive Oxygen Species

Stichwörter der Autor:innen

DNAzymeROS‐responsive prodrugcascade activationsynergistic therapytargeted protein therapyzeolitic pyrimidine framework (ZPF)

Substanzen

ProdrugsDNA, CatalyticPyrimidinesZeolitesAntineoplastic AgentspyrimidineReactive Oxygen Species

Autor:innen und Institutionen

  • Shanghai Engineering Research Center of Green Energy Chemical Engineering, Key Laboratory of Resource Chemistry of Ministry of Education, Shanghai Frontiers Science Center of Biomimetic Catalysis, College of Chemistry a…
  • State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Nan Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai municipality

Zitieren

APA

Huang, Y., Hu, X., Sun, J., Yin, M., & Chen, N. (2026). A Zeolitic Pyrimidine Framework ( ZPF ) Nanoplatform Co‐Delivers a DNAzyme and a Protein Prodrug for Cascade‐Activated Tumour Therapy. Cell Proliferation. https://doi.org/10.1111/cpr.70225

Vancouver

Huang Y, Hu X, Sun J, Yin M, Chen N. A Zeolitic Pyrimidine Framework ( ZPF ) Nanoplatform Co‐Delivers a DNAzyme and a Protein Prodrug for Cascade‐Activated Tumour Therapy. Cell Proliferation. 2026. doi:10.1111/cpr.70225

BibTeX
@article{Huang2026,
  author = {Huang, Yan and Hu, Xingjie and Sun, Jinli and Yin, Min and Chen, Nan},
  title = {A Zeolitic Pyrimidine Framework ( ZPF ) Nanoplatform Co‐Delivers a DNAzyme and a Protein Prodrug for Cascade‐Activated Tumour Therapy},
  journal = {Cell Proliferation},
  year = {2026},
  doi = {10.1111/cpr.70225}
}
Kostenlos starten →